J
JAZZ
Jazz Pharmaceuticals Plc
194.20
-3.94-1.99%Pre Market: 194.08 -0.12 -0.06%08:20 04/13 EDT
OPEN/PREV CLOSE199.70/198.14
TODAY RANGE192.32-200.00
VOL62
MARKET CAP11.96B
52 WEEK RANGE95.49-200.24
AVG VOL (3M)953.47K
% TURNOVER1.47%
TURNOVER0
P/E (TTM)-33.2517
% RANGE3.75%
EPS(TTM)-5.8403
P/E(FORWARD)15.42
P/B2.763
BVPS70.30
DIVIDEND--
P/S2.796
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP11.55B
SHARES OUTSTANDING61.56M
NEXT EARNINGS05/04-05/08
FREE FLOAT59.48M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·1d ago
Is It Too Late To Consider Jazz Pharmaceuticals (JAZZ) After A 93% One Year Rally?
Simply Wall St·2d ago
Does New Epidiolex Behavioral Data at AAN 2026 Reframe Jazz Pharmaceuticals’ (JAZZ) Neuroscience Strategy?
TipRanks·4d ago
Jazz Pharmaceuticals (JAZZ) Gets a Buy from Wells Fargo
TipRanks·5d ago
RBC Capital Remains a Buy on Jazz Pharmaceuticals (JAZZ)
Seeking Alpha·6d ago
Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative
NASDAQ·04/03 15:30
Why Is Keros Therapeutics (KROS) Up 2.5% Since Last Earnings Report?
Reuters·04/01 20:16
Jazz Pharmaceuticals to present at Needham Virtual Healthcare Conference
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.